# A Study to Evaluate Lu AF90103 in Healthy Men

> **NCT04940949** · PHASE1 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lu AF90103
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04940949
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-26
- **Primary completion:** 2021-11-23
- **Final completion:** 2021-11-23
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** The study was terminated based on new safety data.
- **Last updated:** 2023-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04940949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04940949, "A Study to Evaluate Lu AF90103 in Healthy Men". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04940949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*